Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human Progesterone Receptor Anticorps:
anti-Mouse (Murine) Progesterone Receptor Anticorps:
anti-Rat (Rattus) Progesterone Receptor Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Monoclonal Progesterone Receptor Primary Antibody pour IHC (p) - ABIN1688782
Liu, Yang, Li, Guo, Lin, Lang, Shen, Pringle, Zhang, Fu: Invasive micropapillary mucinous carcinoma of the breast is associated with poor prognosis. dans Breast cancer research and treatment 2015
Show all 64 Pubmed References
Human Monoclonal Progesterone Receptor Primary Antibody pour IHC (p) - ABIN1688797
Phrakonkham, Brouland, Saad, Bergès, Pimpie, Pocard, Canivenc-Lavier, Perrot-Applanat: Dietary exposure in utero and during lactation to a mixture of genistein and an anti-androgen fungicide in a rat mammary carcinogenesis model. dans Reproductive toxicology (Elmsford, N.Y.) 2015
Show all 50 Pubmed References
Human Monoclonal Progesterone Receptor Primary Antibody pour ELISA, WB - ABIN969352
Saito, Ito, Nagase, Suzuki, Akahira, Okamura, Yaegashi, Sasano: Progesterone receptor isoforms as a prognostic marker in human endometrial carcinoma. dans Cancer science 2006
Show all 5 Pubmed References
Human Monoclonal Progesterone Receptor Primary Antibody pour ChIP, ICC - ABIN2668242
Rochette-Egly, Lutz, Pfister, Heyberger, Scheuer, Chambon, Gaub: Detection of retinoid X receptors using specific monoclonal and polyclonal antibodies. dans Biochemical and biophysical research communications 1994
Show all 5 Pubmed References
Human Polyclonal Progesterone Receptor Primary Antibody pour WB - ABIN1881650
Van Belle, Van Calster, Brouckaert, Vanden Bempt, Pintens, Harvey, Murray, Naume, Wiedswang, Paridaens, Moerman, Amant, Leunen, Smeets, Drijkoningen, Wildiers, Christiaens, Vergote, Van Huffel, Neven: Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis. dans Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010
Show all 3 Pubmed References
Human Polyclonal Progesterone Receptor Primary Antibody pour WB - ABIN1881649
Geradts, Bean, Bentley, Barry: The oncotype DX recurrence score is correlated with a composite index including routinely reported pathobiologic features. dans Cancer investigation 2010
Show all 3 Pubmed References
Human Monoclonal Progesterone Receptor Primary Antibody pour IF, IHC (p) - ABIN562204
Liu, Chang, Kuo, Hwa, Lin, Huang, Chen, Chang, Hsieh: Major Functional Transcriptome of an Inferred Center Regulator of an ER(-) Breast Cancer Model System. dans Cancer informatics 2012
Show all 2 Pubmed References
Human Monoclonal Progesterone Receptor Primary Antibody pour ELISA, WB - ABIN966829
Polo, José Galindo, Martínez, Alvarez, Arévalo, Asensi, Cánoves, Cáncer, Collazos, Estrada, Gómez-Candela, Johnston, Locutura, López-Aldeguer, Lozano, Miralles, Muñoz-Sanz, Ortega, Pascua, Pedrol, Pulido, San Martín, Sanz, Viciana, Chamorro,: [Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection]. dans Enfermedades infecciosas y microbiología clínica 2006
Show all 4 Pubmed References
Human Monoclonal Progesterone Receptor Primary Antibody pour IHC (fro), IHC - ABIN152361
Pérez, Cuadros, Benítez, Jiménez: Interaction of Alzheimer's disease amyloid beta peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain. dans Journal of Alzheimer's disease : JAD 2004
Show all 2 Pubmed References
Human Monoclonal Progesterone Receptor Primary Antibody pour ELISA - ABIN1724699
Tung, Abdel-Hafiz, Shen, Harvell, Nitao, Richer, Sartorius, Takimoto, Horwitz: Progesterone receptors (PR)-B and -A regulate transcription by different mechanisms: AF-3 exerts regulatory control over coactivator binding to PR-B. dans Molecular endocrinology (Baltimore, Md.) 2006
Show all 2 Pubmed References
We investigate the impact of central histology (n = 772), immunohistochemistry for intrinsic subtyping and IHC4, and dichotomous (GG) or continuous (GGI) genomic grade (n = 472) on patient outcome and benefit from taxane chemotherapy, focusing on HR+/HER2 (Montrer ERBB2 Anticorps)(HR: ER and/or PR)- patients (n = 459)
progesterone receptor expression status correlates with final pregnancy outcome
RA induced loss of PR binding only at the proximal site. Interestingly, RARalpha (Montrer RARA Anticorps) was recruited to the -1.1 kb PRE and the -130 bp PRE/RARE regions with P4, but not RA alone or RA plus P4
C/EBPbeta (Montrer CEBPB Anticorps) negatively regulates PR-B expression in glioblastoma cells.
Evaluation of progesterone expression in axillary lymph node metastasis of ER-positive, HER2 (Montrer ERBB2 Anticorps)-negative breast cancer may enable prediction of patients who are less likely to benefit from adjuvant tamoxifen.
findings suggest that GATAD2B (Montrer GATAD2B Anticorps) serves as an important mediator of progesterone-progesterone receptor suppression of proinflammatory and contractile genes during pregnancy; decreased GATAD2B (Montrer GATAD2B Anticorps) expression near term may contribute to the decline in progesterone receptor function, leading to labor
We sought to determine the relation between 17-alpha hydroxyprogesterone caproate plasma concentrations, progesterone receptor single nucleotide polymorphisms and single nucleotide polymorphisms in CYP3A4 (Montrer CYP3A4 Anticorps) and CYP3A5 (Montrer CYP3A5 Anticorps) and spontaneous preterm birth.
the estrogen- (ER), progesterone- (PgR) and HER2/neu (Montrer ERBB2 Anticorps) receptor status of the primary tumor with brain metastases in a series of 24 consecutive breast cancer patients, is reported.
we found that combinatorial MK-2206+progesterone treatments decreased angiogenesis and proliferation in the Pten (Montrer PTEN Anticorps)(d/d) conditional mouse model of endometrial cancer. Taken together, these findings suggest that a combinatorial therapeutic approach utilizing Akt (Montrer AKT1 Anticorps) inhibitors with progestins may improve the efficacy of progestin therapy for the treatment of endometrial cancer.
The interplay between intracellular progesterone receptor and PRKCA (Montrer PKCa Anticorps)-PRKCD (Montrer PKCd Anticorps) plays a key role in migration and invasion of human glioblastoma cells.
Glandular epithelial androgen receptor (AR (Montrer AR Anticorps)) inactivation (with persistent stromal AR action) enhanced PTEN (Montrer PTEN Anticorps) deletion-induced uterine pathology possibly by downregulating progesterone receptor expression in the uterus.
Studies indicate that progesterone receptor transgenic (Pgrcre/+) mitogen inducible gene 6 (Mig (Montrer CXCL9 Anticorps)-6over) phosphatase and tensin homolog (Montrer PTEN Anticorps) protein (Ptenf/f) knockout mice exhibited an increase of phospho-ERK1/2 (Montrer MAPK1/3 Anticorps) and its target genes.
loss of PGR impairs kisspeptin secretory machinery and therefore that PGR plays a critical role in regulating kisspeptin secretion.
PR isoforms are differentially regulated by estradiol and that the induction of PR-B expression is associated to specific transcription factors interactions and epigenetic changes in its promoter in embryonic hypothalamic cells.
The results show that mPges-1 (Montrer PTGES Anticorps) may be a direct downstream target gene of the progesterone receptor.
Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
generated a model to study the consequence of increased Notch (Montrer NOTCH1 Anticorps) signaling in female reproduction and provide the first evidence, to our knowledge, that Notch (Montrer NOTCH1 Anticorps) signaling can regulate epigenetic modification of the progesterone receptor
Calvarial cells had more potential to differentiate into osteoblasts and displayed more osteogeic markers after the PR expression was ablated from the Mx1+ cells. This indicates that PRs may play a role in the later stages of osteoblast differentiation.
progesterone receptor is a key contributor to the hypoxic ventilatory response in newborn mice
Progesterone receptor rapid and nonclassical transcriptional effects govern breast cancer growth.
Data suggest that the classical xPR-1, located at the plasma membrane, mediates reinitiation of the meiotic cell cycle in the X. laevis oocyte through a non-genomic mechanism.
Xenopus laevis progesterone receptor is capable of associating with the plasma membrane and this association is through its ligang-binding domain.
The expression of progesterone receptor in the uterotubular junction after deep intrauterine insemination with a reduced number of sperm was lower than after conventional artificial insemination and might influence sperm transportation and fertilization.
the digitonin-soluble progesterone binding protein (Montrer PGRMC1 Anticorps) has a binding site that differs from that of membrane PR; it is concluded that more than one progesterone receptor is present in porcine spermatozoa.
The expression of mRNAs for ERalpha (Montrer ESR1 Anticorps), ERbeta (Montrer ESR2 Anticorps) and PR in the sow uterus differed between endometrium and myometrium as well as with stages of the estrous cycle and early pregnancy.
Pgr is widely distributed in all regions of the zebrafish brain.
The localization of Pgr suggests that it mediates progestin regulation of reproductive signaling in the brain, early germ cell proliferation in testis, and ovarian follicular functions, but not final oocyte or sperm maturation.
11 beta-hydroxysteroid dehydrogenase activity stimulated by DHP (Montrer DPYS Anticorps) via Pgr
In vitro and in vivo effects of PGR knockdown in Luteinized granulosa cells also support the hypothesis that Progesterone enhances its own synthesis in the primate corpus luteum by promoting luteinization.
Data suggest that there are no changes in expression or localization patterns for PGR and PGRMC1 (Montrer PGRMC1 Anticorps) (progesterone receptor membrane component 2 (Montrer PGRMC2 Anticorps)) in endometrium in artificially cycled disease-free animals compared with an endometriosis model.
expression differences among PGR genotypes in oviduct and uterus and when differences appear during gestation
During early pregnancy mares had the same pattern of progesterone receptor in the endometrium as that reported for other mammals; namely, a loss of progesterone receptor from the endometrial epithelia but continued localization in stromal cells.
These results indicate that ptger4b expression is regulated by a genomic mechanism involving Pgr.
Progesterone upregulation of Gs proteins increases VIP (Montrer Vip Anticorps)-induced inhibition of intestinal smooth muscle cell contraction mediated by progesterone receptor A.(progesterone receptor A)
This gene encodes a member of the steroid receptor superfamily. The encoded protein mediates the physiological effects of progesterone, which plays a central role in reproductive events associated with the establishment and maintenance of pregnancy. This gene uses two distinct promotors and translation start sites in the first exon to produce two isoforms, A and B. The two isoforms are identical except for the additional 165 amino acids found in the N-terminus of isoform B and mediate their own response genes and physiologic effects with little overlap.
nuclear receptor subfamily 3 group C member 3
, p4 receptor
, Nuclear receptor subfamily 3 group C member 3
, progesterone receptor
, nuclear progesterone receptor Pgr